KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medtronic (MDT) Interest Expenses (2016 - 2026)

Medtronic (MDT) has disclosed Interest Expenses for 13 consecutive years, with $181.0 million as the latest value for Q1 2026.

  • Quarterly Interest Expenses rose 1.12% to $181.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $712.0 million through Jan 2026, down 5.94% year-over-year, with the annual reading at $729.0 million for FY2025, 1.39% up from the prior year.
  • Interest Expenses hit $181.0 million in Q1 2026 for Medtronic, roughly flat from $181.0 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $209.0 million in Q4 2024 to a low of $118.0 million in Q4 2022.
  • Historically, Interest Expenses has averaged $170.6 million across 5 years, with a median of $176.0 million in 2025.
  • Biggest five-year swings in Interest Expenses: soared 52.54% in 2023 and later decreased 13.86% in 2025.
  • Year by year, Interest Expenses stood at $118.0 million in 2022, then soared by 52.54% to $180.0 million in 2023, then grew by 16.11% to $209.0 million in 2024, then dropped by 13.4% to $181.0 million in 2025, then changed by 0.0% to $181.0 million in 2026.
  • Business Quant data shows Interest Expenses for MDT at $181.0 million in Q1 2026, $181.0 million in Q4 2025, and $176.0 million in Q3 2025.